Novo Nordisk limits Wegovy doses for new patients as demand outpaces supply

Novo Nordisk, maker of the weight-loss drug Wegovy, said it would limit supply of starter doses as demand outpaces the company’s manufacturing capacity. 

Article Source: Latest From CNN Read More